Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline
Open Access
- 27 February 2009
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 13 (2), 341-351
- https://doi.org/10.1111/j.1582-4934.2008.00333.x
Abstract
Experimental autoimmune neuritis (EAN) is a widely used animal model of the human acute inflammatory demyelinating polyradiculoneuropathy, which is the most common subtype of Guillain-Barré Syndrome. EAN is pathologically characterized by breakdown of the blood-nerve barrier, infiltration of reactive immune cells, local inflammation, demyelination in the peripheral nervous system and mechanical allodynia. Minocycline is known to have neuroprotective and anti-inflammatory effects. Furthermore, relieve of neuropathic pain following minocycline administration was observed in a variety of animal models. Here, we investigated the effects of minocycline on rat EAN. Suppressive treatment with minocycline (50 mg/kg body weight daily immediately after immunization) significantly attenuated the severity and duration of EAN. Macrophage and T-cell infiltration and demyelination in sciatic nerves of EAN rats treated with minocycline were significantly reduced compared to phosphate-buffered saline (PBS)-treated EAN rats. mRNA expressions of matrix metallopeptidase-9, inducible nitric oxide synthase and pro-inflammatory cytokines interleukin-1 β and tumour necrosis factor-α in EAN sciatic nerves were greatly decreased by administration of minocycline as well. Furthermore, minocycline attenuated mechanical allodynia in EAN rats and greatly suppressed spinal microglial activation. All together, our data showed that minocycline could effectively suppress the peripheral and spinal inflammation (immune activation) to improve outcome in EAN rats, which suggests that minocycline may be considered as a potential candidate of pharmacological treatment for autoimmune-mediated neuropathies.This publication has 49 references indexed in Scilit:
- Mechanisms of Neuropathic PainNeuron, 2006
- Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X4, a key molecule for mechanical allodyniaGlia, 2006
- The immunobiology of Guillain‐Barré syndromesJournal of the Peripheral Nervous System, 2005
- Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in ratsJournal of Neuroscience Research, 2004
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- Inflammatory Mediators and Neonatal Brain DamageNeonatology, 2001
- Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosisBrain, 1999
- Cytokine-regulated proteases in autoimmune diseasesImmunology Today, 1994
- Modulation of the proliferative response of murine thymocytes stimulated by IL-1, and enhancement of IL-1β secretion from mononuclear phagocytes by tetracyclinesJournal of Antimicrobial Chemotherapy, 1990
- The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cordJournal of Comparative Neurology, 1984